These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35080118)

  • 21. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.
    Vyskocil S; Cardin D; Ciavarri J; Conlon J; Cullis C; England D; Gershman R; Gigstad K; Gipson K; Gould A; Greenspan P; Griffin R; Gulavita N; Harrison S; Hu Z; Hu Y; Hata A; Huang J; Huang SC; Janowick D; Jones M; Kolev V; Langston SP; Lee HM; Li G; Lok D; Ma L; Mai D; Malley J; Matsuda A; Mizutani H; Mizutani M; Molchanova N; Nunes E; Pusalkar S; Renou C; Rowland S; Sato Y; Shaw M; Shen L; Shi Z; Skene R; Soucy F; Stroud S; Xu H; Xu T; Abu-Yousif AO; Zhang J
    J Med Chem; 2021 May; 64(10):6902-6923. PubMed ID: 34000802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unlocking the promise of systemic STING agonist for cancer immunotherapy.
    Sun X; Zhou X; Lei YL; Moon JJ
    J Control Release; 2023 May; 357():417-421. PubMed ID: 37001564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy.
    Wilson DR; Sen R; Sunshine JC; Pardoll DM; Green JJ; Kim YJ
    Nanomedicine; 2018 Feb; 14(2):237-246. PubMed ID: 29127039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation.
    Zhang BD; Wu JJ; Li WH; Hu HG; Zhao L; He PY; Zhao YF; Li YM
    Nano Res; 2022; 15(7):6328-6339. PubMed ID: 35464625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No magnesium is needed for binding of the stimulator of interferon genes to cyclic dinucleotides.
    Smola M; Birkus G; Boura E
    Acta Crystallogr F Struct Biol Commun; 2019 Sep; 75(Pt 9):593-598. PubMed ID: 31475926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of STING agonists for adjuvanting subunit vaccines.
    Van Herck S; Feng B; Tang L
    Adv Drug Deliv Rev; 2021 Dec; 179():114020. PubMed ID: 34756942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STING Signaling in Cancer Cells: Important or Not?
    Sokolowska O; Nowis D
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
    Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
    J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Cyclic Dinucleotides by STING.
    Du XX; Su XD
    Methods Mol Biol; 2017; 1657():59-69. PubMed ID: 28889286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into the dichotomous regulation of STING activation in immunotherapy.
    Hu Z; Yang Y; Fang L; Zhou J; Zhang H
    Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):126-137. PubMed ID: 33618600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of the Binding Mechanism of Cyclic Dinucleotide Analogs to Stimulating Factor Proteins and the Implications for Subsequent Analog Drug Design.
    Yuan SW; Shi HL; Fu MR; Zhang XC; Xi XQ; Wang Y; Shen TS; Ma JL; Tang CD
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling.
    Konno H; Konno K; Barber GN
    Cell; 2013 Oct; 155(3):688-98. PubMed ID: 24119841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Protein Upregulation of STING for Boosting the Efficacy of Immunotherapy.
    Cho W; Won S; Choi Y; Yi S; Park JB; Park JG; Kim CE; Narayana C; Kim JH; Yim J; Choi YI; Lee DS; Park SB
    Angew Chem Int Ed Engl; 2023 Apr; 62(18):e202300978. PubMed ID: 36827625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulator of interferon genes (STING) activation exacerbates experimental colitis in mice.
    Martin GR; Blomquist CM; Henare KL; Jirik FR
    Sci Rep; 2019 Oct; 9(1):14281. PubMed ID: 31582793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structures of porcine STING
    Cong X; Yuan Z; Du Y; Wu B; Lu D; Wu X; Zhang Y; Li F; Wei B; Li J; Wu J; Xu S; Wang J; Qi J; Shang G; Gu L
    J Biol Chem; 2019 Jul; 294(30):11420-11432. PubMed ID: 31167783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-Ligand Interactions in the STING Binding Site Probed by Rationally Designed Single-Point Mutations: Experiment and Theory.
    Vavřina Z; Gutten O; Smola M; Zavřel M; Aliakbar Tehrani Z; Charvát V; Kožíšek M; Boura E; Birkuš G; Rulíšek L
    Biochemistry; 2021 Mar; 60(8):607-620. PubMed ID: 33586948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cGAS-STING pathway in cancer biotherapy.
    Wang Y; Luo J; Alu A; Han X; Wei Y; Wei X
    Mol Cancer; 2020 Sep; 19(1):136. PubMed ID: 32887628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2',3'-Cyclic GMP-AMP Dinucleotides for STING-Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis.
    Shang M; Lu K; Guan W; Cao S; Ren M; Zhou C
    ChemMedChem; 2022 Jan; 17(2):e202100671. PubMed ID: 34807508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STING Activation and its Application in Immuno-Oncology.
    Lian Y; Duffy KJ; Yang J
    Curr Top Med Chem; 2019; 19(24):2205-2227. PubMed ID: 31642767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective Loss of Responsiveness to Exogenous but Not Endogenous Cyclic-Dinucleotides in Mice Expressing STING-R231H.
    Walker MM; Kim S; Crisler WJ; Nguyen K; Lenz LL; Cambier JC; Getahun A
    Front Immunol; 2020; 11():238. PubMed ID: 32153571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.